Ilsi Na: Am2016: Adverse Effects: Consideration Of Chronic Disease Endpoints

ILSI NA: AM2016: Adverse Effects: Consideration of Chronic Disease Endpoints (Amanda MacFarlane)

ILSI NA: AM2016: Adverse Effects: Experience in Developing DRIs (Linda Meyers)

ILSI NA: AM2016: Adverse Health Effects: From Added Food Ingredients to Nutrients (Joseph Rodricks)

ILSI NA: AM2016: How Do We Define the Continuum – from Perturbation to Adverse Effects? (Q&A )

ILSI NA: EB 2017: Results of Specific Health Endpoints: Behavior...

ILSI NA: New DRIs for Sodium and Potassium (Virginia Stallings)

ILSI NA: IAFP 2016: The Human Microbiome and Disease (Vincent Young)

ILSI NA: AM2016: Overview on Current State of the Science on Dietary Exposure Assessment (Nga Tran)

ILSI NA: AM2016: What are the Emerging Issues and the Way Forward? (Panel Discussion)

ILSI NA: IAFP 2016: Regulatory Perspective and Associated Human Health.... (Lesley D'Anglada)

ILSI NA: AM2016: Welcome, Introductory Remarks and Objectives (Christine Taylor)

ILSI NA: AM2016: Why Cognition is Key to Understanding Food Intake: (Jeffrey Brunstrom)

ILSI NA: IAFP 2015: Regulatory Credibility

ILSI NA/ASN: EB2016: The Requirement of Research Data by Federal Agencies (Barbara Schneeman)

ILSI NA: AM2016: Beyond Appetite: New Perspectives on Eating Behavior (Panel Session)

ILSI NA: ASN2018: Relationship of Sodium and Potassium to Chronic Disease (Janet de Jesus)

ILSI NA: The Evolution and Continuing Importance of Risk-based Decisions…(Joseph Rodricks, PhD)

ILSI NA: Protection by prebiotic fibers in chronic immological disorders (Leo Dieteman)

ILSI NA: AM2016: Advances in Methodology: Food Safety and Dietary Intake (Janet Cade)